1. Chronic naloxone treatment induced supersensitivity to a mu but not kappa agonist at the hypothalamus-pituitary-adrenocortical axis level;Alcaráz;J. Pharmacol. Exp. Ther.,1993
2. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions spinal cord;Bhargava;J. Pharmacol. Exp. Ther.,1989
3. Structure-function on the cloned opiate receptors: peptide and small molecular interactions;Blake;Chemistry Biology,1996
4. Pharmacological characterization of opioid receptor influencing the secretion of corticotrophin-releasing factor in the rat;Buckingham;Neuroendocrinology,1986
5. Role of plasma catecholamines in eliciting cardiovascular changes seen during naloxone-precipitated withdrawal in conscious, unrestrained morphine-dependent rats;Chang;J. Pharmacol. Exp. Ther.,1990